Analysis of the parameters of oxidative stress in patients with Parkinson's disease

被引:1
|
作者
Nikolova G. [1 ]
Mancheva V. [2 ]
机构
[1] Department of Chemistry and Biochemistry, Medical Faculty, Trakia University, Armejska street 11
[2] Department of Neurology and Psychiatry, Medical Faculty, Trakia University Hospital, Armeiska Street, 11
关键词
CAT; MDA; Neurodegenerative diseases; Oxidative stress; SOD;
D O I
10.1007/s00580-012-1407-8
中图分类号
学科分类号
摘要
The increasing data provides enough evidences confirming the involvement of free radicals and other reactive oxygen species (ROS) superoxide radical (.O2-), nitric oxide (NO.), hydrogen peroxide (H2O2) and hydroxyl radicals (.OH) in a number of physiological and pathological processes. Imbalance between levels of ROS resulting in the body and the capacity of antioxidant defense mechanisms occur oxidative stress (OS). OS is related to a number of structural and functional damages to cells and is involved in the pathogenesis of many diseases, including neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease (PD), amyotrophic lateral sclerosis, and Huntington disease. Defects in oxidative phosphorylation and oxidative damage play an important role in neurodegenerative diseases. The aim of this study was to investigate some biomarkers of OS such as the level of lipid peroxidation measured as malondialdehyde (MDA) reactive products and activity of antioxidant enzymes superoxide dismutase (SOD) and catalase (CAT) in the blood of PD patients compared with control group of healthy volunteers. By the present research we report higher levels of MDA products and an imbalance in SOD and CAT enzyme activities in PD patients compared to the control group. © 2012 Springer-Verlag London Limited.
引用
收藏
页码:151 / 155
页数:4
相关论文
共 50 条
  • [41] Mitochondrial dysfunction and oxidative stress in Parkinson's disease
    Subramaniam, Sudhakar Raja
    Chesselet, Marie-Francoise
    PROGRESS IN NEUROBIOLOGY, 2013, 106 : 17 - 32
  • [42] Mitochondrial Dysfunction and Oxidative Stress in Parkinson’s Disease
    Isaac G. Onyango
    Neurochemical Research, 2008, 33 : 589 - 597
  • [43] A Panel of Oxidative Stress Markers in Parkinson's Disease
    Bolner, A.
    Micciolo, R.
    Bosello, O.
    Nordera, Gp.
    CLINICAL LABORATORY, 2016, 62 (1-2) : 105 - 112
  • [44] Oxidative stress and genetics in the pathogenesis of Parkinson's disease
    Zhang, Y
    Dawson, VL
    Dawson, TM
    NEUROBIOLOGY OF DISEASE, 2000, 7 (04) : 240 - 250
  • [45] Metallothionein isoforms in oxidative stress of Parkinson's disease
    Ebadi, M
    JOURNAL OF NEUROCHEMISTRY, 1999, 72 : S1 - S1
  • [46] Parkinson’s disease: oxidative stress and therapeutic approaches
    Sankar Surendran
    Srinivasagam Rajasankar
    Neurological Sciences, 2010, 31 : 531 - 540
  • [47] Mitochondrial dysfunction and oxidative stress in Parkinson's disease
    Hattori, N
    Tanaka, M
    Mizuno, Y
    JOURNAL OF NEUROCHEMISTRY, 1996, 67 : S33 - S33
  • [48] Synuclein, dopainine, and oxidative stress in Parkinson's disease
    Maguire-Zeiss, KA
    Hoff, SA
    Su, X
    Yehling, E
    Federoff, HJ
    MOVEMENT DISORDERS, 2006, 21 : S65 - S65
  • [49] Mitochondrial dysfunction and oxidative stress in Parkinson's disease
    Onyango, Isaac G.
    NEUROCHEMICAL RESEARCH, 2008, 33 (03) : 589 - 597
  • [50] Cytogenetic analysis oxidative damage in lymphocytes of Parkinson's disease patients
    L. Petrozzi
    C. Lucetti
    G. Gambaccini
    S. Bernardini
    P. Del Dotto
    L. Migliore
    R. Scarpato
    U. Bonuccelli
    Neurological Sciences, 2001, 22 : 83 - 84